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Visual impairment is associated with physical
and mental comorbidities in older adults:
a cross-sectional study
Helen Court1*, Gary McLean2, Bruce Guthrie3, Stewart W Mercer2 and Daniel J Smith1
Abstract
Background: Visual impairment is common in older people and the presence of additional health conditions can
compromise health and rehabilitation outcomes. A small number of studies have suggested that comorbities are
common in visual impairment; however, those studies have relied on self-report and have assessed a relatively
limited number of comorbid conditions.
Methods: We conducted a cross-sectional analysis of a dataset of 291,169 registered patients (65-years-old and over)
within 314 primary care practices in Scotland, UK. Visual impairment was identified using Read Code ever recorded for
blindness and/or low vision (within electronic medical records). Prevalence, odds ratios (from prevalence rates
standardised by stratifying individuals by age groups (65 to 69 years; 70 to 74; 75 to 79; 80 to 84; and 85 and over),
gender and deprivation quintiles) and 95% confidence intervals (95% CI) of 37 individual chronic physical/mental
health conditions and total number of conditions were calculated and compared for those with visual impairment
to those without.
Results: Twenty seven of the 29 physical health conditions and all eight mental health conditions were
significantly more likely to be recorded for individuals with visual impairment compared to individuals without
visual impairment, after standardising for age, gender and social deprivation. Individuals with visual impairment
were also significantly more likely to have more comorbidities (for example, five or more conditions
(odds ratio (OR) 2.05 95% CI 1.94 to 2.18)).
Conclusions: Patients aged 65 years and older with visual impairment have a broad range of physical and mental
health comorbidities compared to those of the same age without visual impairment, and are more likely to have
multiple comorbidities. This has important implications for clinical practice and for the future design of integrated
services to meet the complex needs of patients with visual impairment, for example, embedding depression and
hearing screening within eye care services.
Keywords: Visual impairment, Comorbidity, Primary care
Background
The prevalence of visual impairment increases rapidly
with age. It is estimated that more than one in ten of the
older UK population suffer from significant visual im-
pairment, which rises to one in three of those more than
90-years old [1]. Visual impairment impacts on every part
of a person’s life. It is associated with falls [2-5], reduced
capacity to carry out everyday activities [6], the need for
residential care [7], and is one of the strongest risk factors
for functional status decline in community-living people [8].
However, because older people often have multiple health
problems [9], many of these individuals may also have add-
itional health conditions which further compromise health
and rehabilitation outcomes, including reduced quality of
life, disability, increased healthcare costs, increased inpatient
admissions and higher death rates [10-15].
Knowledge about comorbidity in visual impairment is
sparse, with only a limited number of studies that describe
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the nature and extent of comorbidities. Crews used US
national survey data to examine the prevalence of nine
conditions in older people with visual impairment and ef-
fects upon functioning [16]. All nine conditions (breathing
problems, depression, diabetes, heart problems, hearing
impairment, hypertension, joint problems, lower back pain
and stroke) were more common in people with visual im-
pairment and were associated with increased difficulties in
walking and climbing steps, shopping and socialising [14].
Van Nispen et al. also reported an observational study of
296 visually impaired patients and identified that only 25%
had no comorbidities and that comorbidity was associated
with decreased levels of health-related quality of life [17].
However, although these studies identify that comorbidi-
ties are common for people with visual impairment, they
are limited by self-report measures and by a relatively lim-
ited number of comorbid conditions assessed.
Understanding the nature and extent of comorbidity
in this group will help to inform decisions about how
medical practice and healthcare services can be improved
for individuals with visual impairment, for example, with
respect to integration with other healthcare specialities. In
this study, we take visual impairment as an index condition
and describe the rates and patterns of comorbidity of 29
chronic physical health conditions and eight mental health
conditions. To our knowledge, this is the largest single
study of visual impairment and comorbidity to date.
Methods
We used data from the Primary Care Clinical Informatics
Unit at the University of Aberdeen for all 1,751,841 regis-
tered patients who were alive and permanently registered
with 314 Scottish general practices on 31 March 2007. Data
on the presence of 32 common chronic physical health con-
ditions (including visual impairment) and 8 mental health
conditions were extracted (listed in Additional file 1).
The included patients are representative of the whole
Scottish population in terms of age, sex and socioeconomic
deprivation [18] and a more detailed explanation of the
dataset is available elsewhere [9]. GPs do not routinely
record detailed quantitative data about sight such as visual
acuity, but will code what they consider to be significant
morbidity using Read Codes which are the morbidity coding
system used in all UK primary care medical records. The set
of Read Codes we used was one created by NHS Scotland
Information Services Division to define visual impair-
ment for the purposes of analysing an NHS Scotland
general practice morbidity recording national dataset
(Practice Team Information) (a full list of the Read Codes
used is provided in Appendix 1) [19].
Socioeconomic deprivation was measured using the
Carstairs deprivation score divided into quintiles
(from most affluent to most deprived). The Carstairs
score is based on postcode of residence and is widely
used in healthcare research as a measure of socioeconomic
status [20]. We restricted our analyses to those 65 years old
and older, in order to focus on age-related visual impair-
ment. The sample was sub-divided into the following age
groups for analysis: 65 to 69 years; 70 to 74; 75 to 79; 80 to
84; and 85 and older.
Age-gender specific rates were generated by the five
age groups defined above and by deprivation quintiles
for men and women. To control for differences between
the two populations in age, gender and deprivation levels
we generated standardised prevalence rates by age group
(65 to 69 years; 70 to 74; 75 to 79; 80 to 84; and 85 and
older), gender and deprivation quintile using the direct
method. These age-gender-deprivation standardised
rates were then used to calculate odds ratios (ORs) and
95% confidence intervals (95% CI) for those with visual
impairment compared to those without visual impairment
(controls) for the prevalence of 29 physical conditions
(two conditions were excluded: glaucoma since it is a
purely ocular condition, and viral hepatitis because only
one person with visual impairment had this condition)
and eight mental health conditions (depression, alcohol
misuse, ‘other psychoactive substance abuse’, learning
disability, anorexia/bulimia, ‘anxiety and other neurotic,
stress-related and somatoform disorders’, ‘schizophrenia
and related conditions’, and dementia), as well as by the
number of overall conditions and the number of physical
and mental health conditions.
We used t tests to analyse differences for mean age
and deprivation score and one-way analysis of variance
for differences across age groups and deprivation quin-
tiles. For all statistical analyses, a P-value less than 0.05
was considered statistically significant. All analyses were
performed in Stata version 13. The NHS Grampian
Research Ethics Service approved the anonymous use
of these data for research purposes.
Results
Demographics
We identified 5,348 (1.8% of the sample) patients with a
Read code for visual impairment (Table 1). Women were
over-represented in the visual impairment group compared
to controls (63.2% versus 57.1% for controls; P <0.001).
Individuals with recorded visual impairment tended to
be older (mean age 80.9 years versus 74.9 years for controls;
P <0.001), with 37.1% 80 years old or older compared to
12.1% of controls and were also more likely to be socially
deprived (visual impairment Carstairs score 0.08 versus
controls −0.35; P <0.001) although differences between
quintiles were small.
Comorbidities: visual impairment versus controls
Overall 95.0% of individuals with visual impairment had at
least one other condition compared to 84.5% of controls
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(P <0.001) (Table 2). Whilst controls were more likely
to have one (visually impaired 9.9% versus controls
19.7%; OR 0.55 95% CI (0.50 to 0.60)) or two (visually
impaired 14.7% versus controls 19.9%; OR 0.72 95% CI
(0.67 to 0.78)) conditions, those in the visual impairment
group were significantly more likely to have four con-
ditions (visually impaired 15.4% versus controls 11.7%;
OR 1.17 95% CI 1.08 to 1.26) and five or more conditions
(visually impaired 37.4% versus controls 17.8%; OR 2.05
95% CI 1.94 to 2.18) (Table 2) (even after standardising for
age, sex and social deprivation).
A similar finding was found when restricting analysis
only to physical health comorbidities, but differences
were greater for mental health comorbidity. Members of
the visual impairment group were less likely to have no
recorded mental health condition compared to controls
(visually impaired 60.6% versus controls 76.1%; OR 0.63,
95% CI 0.59 to 0.67). Furthermore, 15% of the visual im-
pairment group had two or more mental health conditions
compared to only 7.5% of controls (P <0.001).
Physical health conditions: visual impairment versus controls
For the visual impairment group, 27 out of 29 physical
conditions were significantly more prevalent relative to
controls, with only bronchiectasis and migraine showing
no significant differences (Table 3). The largest differences
after standardisation for age, sex and deprivation were
for multiple sclerosis (0R 3.31, 95% CI 2.43 to 4.51) and
diabetes (OR 2.76, 95% CI 2.60 to 2.93), both of which are
recognised antecedents of visual impairment. The most
commonly diagnosed condition for those with visual im-
pairment was hypertension, recorded for 55.6% compared
to 46.7% of controls (OR 1.40, 95% CI 1.33 to 1.48).
Mental health conditions: visual impairment versus controls
Depression had the largest prevalence for the individual
mental health conditions (visually impaired 18.2% versus
controls 12.0%; OR 1.53, 95% CI 1.43 to 1.65) and Table 4
highlights that those with visual impairment had sig-
nificantly higher prevalence for all eight mental health
conditions. The biggest difference after standardisation
for age, sex and deprivation was for learning disability
(visually impaired 0.5% versus controls 0.2%; OR 3.31,
95% CI 2.20 to 4.97), followed by anorexia or bulimia
(visually impaired 0.5% versus controls 0.2%; OR 2.23,
95% CI 1.51 to 3.28) (although clearly the absolute preva-
lences of these conditions were low) and for any ‘other
psychoactive substance misuse’ which is a heterogeneous
grouping of problematic use of non-prescription and
prescription drugs ever recorded (visually impaired 12.9%
versus controls 4.8%; OR 1.79, 95% CI 1.65 to 1.95).
Discussion
We found that patients aged 65 years and older with vis-
ual impairment within primary care were characterised
by more medical comorbidities relative to non-visually
impaired controls and that these differences were not
accounted for by age, gender and social deprivation. Indeed,
after standardisation those in the visual impairment group
were twice as likely to have five or more physical/mental
health comorbidities.
Possible explanations and implications for clinicians and
policy makers
Causality cannot be directly inferred from these cross-
sectional data, but it is known that many chronic con-
ditions have visual consequences. For example, optic
neuritis occurs in 70% of MS cases [21], the ocular com-
plications of diabetes account for the majority of blind
registrations in the UK among working age adults [22]
and stroke causes visual impairment in 30% of cases [23].
Other conditions, such as learning disability (more than
three times more likely in the visual impairment group)
are associated with a high prevalence of visual defects from
childhood [24]. Notably, hypertension (55.6%), coronary
heart disease (28.8%) and diabetes (25.9%) were the most
prevalent conditions in the visually impaired group,
and visual impairment may pose significant barriers to
encouraging a healthy lifestyle in this population. Vis-
ual impairment may contribute to a compromised diet
(due to difficulty in preparing food), increased difficulties
engaging in exercise, and high levels of isolation and
loneliness. Management of these conditions in patients
with visual impairment will require active integration
Table 1 Age, gender and deprivation status, visual
impairment versus controls
Variable Visual impairment No visual impairment
Total (%) 5,348 (1.8%) 285,821 (98.2%)
Gender (% male) 1,968 (36.8%) 122,745 (42.9%)
Mean age (sd) 80.9 (7.3) 74.9 (8.4)
Deprivation mean (sd) 0.08 (3.3) -0.35 (3.2)
Age group (years) Number (%) Number (%)
65 to 69 626 (11.7) 82,976 (29.0)
70 to 74 739 (13.8) 70,939 (24.8)
75 to 79 890 (16.6) 57,311 (20.1)
80 to 84 1,111 (20.7) 40,008 (14.0)
85 and older 1,982 (37.1) 34,587 (12.1)
Deprivation quintile Number (%) Number (%)
Least deprived 827 (15.5) 54,281 (18.9)
2 1,132 (21.2) 66,523 (23.3)
3 1,334 (24.9) 65,759 (23.0)
4 977 (18.3) 52,774 (18.5)
Most deprived 1,078 (20.2) 46,484 (16.3)
All difference significant at P <0.001. sd, standard deviation.
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of clinical, social and rehabilitation services to help im-
prove health.
Clinicians also need to be alert to depression and hearing
loss which will be more common in their patients with vis-
ual impairment compared to those without, and which are
likely to complicate management of other comorbid condi-
tions they are dealing with. Visual impairment is a recog-
nised risk factor for depression which was identified as the
most prevalent mental health condition (18.2%); this is
broadly consistent with previous prevalence estimates for
this group (13.5% to 33% [25-27]). Comorbid hearing loss
was also identified in 17.7% of people in this study, com-
pared to only 9.3% in controls. Both depression and hearing
loss are commonly underdiagnosed within primary care
services [28,29] and have been related to loss of functional
independence, increased risk of falls, hospitalisation and
mortality [30-32]. Identifying and managing depression and
hearing loss will require increased integration between ser-
vices (including rehabilitation and social services) and clear
referral pathways. Integration of depression screening and
integrated depression treatment within eye care services is
currently being evaluated [33,34]. Recommendations have
also been made to integrate hearing screening tests into the
eye care and rehabilitation services, which could substan-
tially increase the numbers of people identified with hearing
loss [28,35]. There is also recent evidence of Governmental
commitment to tackling comorbid depression and dual
sensory loss at national levels [36]. These advancements
represent a move towards integrating services, but con-
tinuing integration to provide holistic care for patients
will require more evidence based recommendations and
commitment from the healthcare community.
Conversely, checking for and taking account of visual
impairment is important for those providing care for other
conditions. Clinicians need to be mindful of the increased
falls risk in visual impairment when prescribing drugs
for comorbid physical/mental health conditions which
could also contribute to falls (for example, hypotensive
and hypoglycaemic agents, bladder anticholinergics,
opioid analgesics, sedative and psychotropic drugs), or in
relation to safe medicines use especially when regimens
are complex.
Strengths and weaknesses
The study is a cross sectional analysis of patients in
primary care using diagnostic criteria based on records
within a primary care database. Recording of disease will,
therefore, not be as accurate or consistent as it would
be in a more formal epidemiological survey. Compared
to the relatively few studies which have examined comor-
bidity in visual impairment [16,17], strengths of our study
include the large sample size and the assessment of a much
wider range of comorbid physical and mental conditions.
Further, this study does not rely on patient self-report of
Table 2 Prevalence and odds ratio for number and type of comorbidities (standardised by age, gender and deprivation score)
Total number of morbidities Visual impairment
Number (%)
No visual impairment
Number (%)
Odds ratio (95% CI)
(standardised by age,
gender and deprivation)
None 269 (5.0) 41,540 (14.5) 0.43 (0.38 to 0.49)
One 534 (9.9) 56,166 (19.7) 0.55 (0.50 to 0.60)
Two 784 (14.7) 56,927 (19.9) 0.72 (0.67 to 0.78)
Three 935 (17.5) 46,758 (16.4) 1.02 (0.94 to 1.09)
Four 825 (15.4) 33,565 (11.7) 1.17 (1.08 to 1.26)
Five or more 2,001 (37.4) 50,865 (17.8) 2.05 (1.94 to 2.18)
Total number of physical conditions
None 339 (16.4) 46,761 (16.4) 0.39 (0.34 to 0.44)
One 681 (12.7) 63,010 (22.1) 0.59 (0.55 to 0.64)
Two 992 (18.6) 61,917 (21.7) 0.84 (0.78 to 0.90)
Three 1,047 (19.6) 47,356 (16.6) 1.12 (1.04 to 1.19)
Four 840 (15.7) 31,054 (10.9) 1.28 (1.19 to 1.35)
Five or more 1,449 (27.1) 35,723 (12.5) 1.99 (1.87 to 2.12)
Total number of mental health conditions
None 3,242 (60.6) 217,579 (76.1) 0.63 (0.59 to 0.67)
One 1,303 (24.4) 46,993 (16.4) 1.32 (1.23 to 1.41)
Two 606 (11.3) 17,036 (6.0) 1.53 (1.40 to 1.67)
Three or more 197 (3.7) 4,213 (1.5) 1.76 (1.51 to 2.04)
All difference significant at P <0.001.
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Table 4 Prevalence and odds ratios for individual mental health conditions (standardised by age, gender and
deprivation score)
Condition Visual impairment
Number (%)
No visual impairment
Number (%)
Odds ratio (95% CI) (standardised
by age, gender and deprivation)
Learning disability 25 (0.5) 559 (0.2) 3.31 (2.20 to 4.97)
Anorexia or bulimia 28 (0.5) 572 (0.2) 2.23 (1.51 to 3.28)
Other psychoactive substance misuse 688 (12.9) 13,568 (4.8) 1.79 (1.65 to 1.95)
Anxiety and other neurotic, stress related and somatoform disorders 763 (14.3) 23,015 (8.1) 1.60 (1.47 to 1.73)
Depression 972 (18.2) 35,067 (12.0) 1.53 (1.43 to 1.65)
Alcohol misuse 174 (3.3) 8,565 (3.0) 1.46 (1.25 to 1.71)
Schizophrenia (and related non-organic psychosis) or bipolar disorder 75 (1.4) 2,873 (1.0) 1.42 (1.13 to 1.80) P = 0.003
Dementia 418 (7.2) 10,110 (3.5) 1.14 (1.02 to 2.27) P = 0.01
All difference significant at P <0.001 except where stated. Conditions are ordered by size of odds ratio (largest to smallest).
Table 3 Prevalence and odds ratios for individual physical conditions (standardised by age, gender and deprivation score)
Condition Visual impairment
Number (%)
No visual impairment
Number (%)
Odds ratio (95% CI) (standardised
by age, gender and deprivation)
Multiple sclerosis (MS) 25 (0.5) 700 (0.2) 3.31 (2.43 to 4.51)
Diabetes 1,386 (25.9) 37,358 (13.1) 2.76 (2.60 to 2.93)
Epilepsy 80 (1.5) 2,850 (1.0) 2.02 (1.66 to 2.46)
Stroke or transient ischaemic attack 989 (18.5) 26,683 (9.3) 1.97 (1.84 to 2.12)
Cirrhosis/chronic liver disease/alcoholic liver disease 19 (0.4) 775 (0.3) 1.97 (1.25 to 3.13) P = 0.004
Peripheral vascular diseases (PVD) 455 (8.5) 14,199 (5.0) 1.74 (1.58 to 1.92)
Constipation 993 (18.6) 24,523 (8.6) 1.72 (1.59 to 1.86)
Psoriasis or eczema 84 (1.6) 2,929 (1.0) 1.67 (1.35 to 2.07)
Heart failure 505 (9.4) 14,263 (5.0) 1.64 (1.48 to 1.81)
Hearing loss 944 (17.7) 26,632 (9.3) 1.60 (1.48 to 1.73)
Chronic sinusitis 51 (0.9) 2,101 (0.7) 1.58 (1.19 to 2.09)
Chronic kidney disease 897 (16.8) 27,515 (9.6) 1.55 (1.43 to 1.68)
Bronchitis, emphysema and other chronic obstructive
pulmonary diseases (COPD)
748 (14.0) 28,790 (10.1) 1.51 (1.40 to 1.63)
Inflammatory arthritis 778 (14.6) 28,097 (9.8) 1.50 (1.39 to 1.63)
Inflammatory bowel disease 66 (1.2) 2,691 (0.9) 1.49 (1.18 to 1.83) P = 0.01
Hypertension 2,972 (55.6) 133,429 (46.7) 1.40 (1.33 to 1.48)
Prostate disease 262 (4.9) 10,164 (3.6) 1.38 (1.22 to 1.57)
Coronary heart disease 1,542 (28.8) 58,160 (20.4) 1.39 (1.31 to 1.48)
Parkinson’s disease 75 (1.4) 2,257 (0.8) 1.34 (1.03 to 1.75)
Painful condition 1,154 (21.6) 54,120 (18.9) 1.29 (1.21 to 1.37)
Irritable bowel syndrome 243 (4.5) 11,450 (4.0) 1.28 (1.13 to 1.45)
Atrial fibrillation 599 (11.2) 19,107 (6.7) 1.26 (1.15 to 1.40)
Dyspepsia 729 (13.6) 32,848 (11.5) 1.22 (1.12 to 1.32)
Diverticular 664 (12.4) 24,053 (8.4) 1.21 (1.11 to 1.33)
Asthma (active) 348 (6.5) 18,654 (6.5) 1.20 (1.08 to 1.32)
New cancer in the last 5 years 578 (10.1) 23,638 (8.3) 1.19 (1.08 to 1.30)
Thyrotoxicosis/thyroid disorders (includes hypothyroidism) 724 (13.5) 31,757 (11.1) 1.14 (1.05 to 1.23) P = 0.03
Bronchiectasis 31 (0.6) 1,575 (0.6) 1.07 (0.75 to 1.57) P = 0.69
Migraine 16 (0.3) 1,207 (0.4) 1.02 (0.67 to 1.54) P = 0.74
All difference significant at P <0.001 except where stated. Conditions are ordered by size of odds ratio (largest to smallest).
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comorbidities and takes account of confounders, such as
age, gender and social deprivation. An important limita-
tion is that visual impairment is based on GP recording
of one or more Read Codes rather than formal measure-
ment of visual function. The Read Codes used were a
broad set which do not always clearly define the exact
nature of the visual impairment, and visual impairment
is under-recorded compared to epidemiological estimates
[1]. However, our expectation is that most people with
very severe impairment will have been coded. From this
perspective, the finding that 1.8% of the sample was de-
fined as having visual impairment is consistent with 0.5%
of Scottish residents being formally registered as visually
impaired, which is known to include only about half of
those eligible for registration [37]. Registration can only be
done by a consultant ophthalmologist with clear visual
acuity and visual field criteria defining ‘partially-sighted’
or ‘blind’ registration. The study reported by Van Nispen
[17] had clear clinical inclusion criteria for patients with
visual impairment, including assessment by an ophthal-
mologist, but it is important to recognise that this require-
ment in itself is likely systematically to exclude the very
frail and people who are housebound or resident in care-
homes. All studies in this area are, therefore, likely to be
biased in some way, and the limitations of our study are
inevitable in all studies relying on routine clinical coding,
even in Scottish primary care where use of electronic
medical records is longstanding and coding reasonably re-
liable. However, these limitations have to be balanced
against the ability to analyse data from very large repre-
sentative samples, and we believe the findings are valid.
Additional limitations are that there may be reporting
bias, where people who attend frequently are more likely
to have all clinical conditions recorded, in which case
people with visual impairment recorded will also be more
likely to have other conditions recorded, and that we were
only able to control for three confounding variables.
Reporting bias is likely to be present to some extent, but
we believe the impact of this is likely to be small because
patients in the UK are required to register with a single
practice to access National Health Service care, and their
clinical record is automatically transferred when they
change practice. All specialists write to the GP and, there-
fore, populate the primary care record. Reporting bias in
cradle-to-grave record is less likely than in one where
records are created anew every time patients register,
although may be present for conditions where patients
may significantly self-care (for example constipation) than
ones where registers are more complete (for example,
ischaemic heart disease). If present, reporting bias would
be expected to somewhat inflate the odds ratios of having
comorbidity in people with visual impairment compared
to those without, but would have less influence on the
estimates of comorbidity rates in the visually impaired
population. With regard to other confounders, we were
restricted by what data were available. Clinical records
do not reliably record marital status, income, occupation
or education, but do reliably record address/postcode.
We, therefore, used postcode assigned socioeconomic
status, gender and age because we had near complete
data on them. However, this represents the trade-off
between large and representative routine data analyses
and more detailed epidemiological studies which are likely
to be smaller and likely less representative (because the
sickest and frailest will not take part). Moreover, indicators
such as income, occupation or education are likely to be
strongly correlated with each and, therefore, at least partly
accounted for by measures of socioeconomic status such
as the Carstairs score used in this study.
Future research
The current study is a cross-sectional analysis. Cohort
studies are required to enable causality of visual impair-
ment and comorbidities to be explored further. Little is
known about how visual impairment interacts with the
genesis or progression of other diseases. For example, it
is not clear how poor lifestyle factors (diet, exercise)
which are compounded by visual impairment might con-
tribute to hypertension and coronary heart disease. This is
an important area for policy and research. Future research
should seek to determine if there are cost-effective inter-
ventions which may help manage or prevent comorbidi-
ties, for example, nutritional and/or exercise interventions
for elderly patients with visual impairment. Additionally,
although there are incentives for GPs to record more
accurate and complete registers of some comorbidities,
this is not the case for visual impairment. Therefore, in
accordance with recommendations made in the re-
cently published Chief Medical Officer’s annual report
[38], improvement in the quantity and quality of visual
(and other sensory) impairment data would help inform fu-
ture developments to local and national services for people
with visual impairment.
Conclusions
Comorbidity is common in patients aged 65 years and
older with visual impairment, with high rates of multiple
comorbidities in this group. Meeting patient needs and
the challenges posed by visual impairment will require
an integrated, multilevel approach which takes account
of the clinical complexity of coexisting health conditions
in this vulnerable patient group.
Appendix 1
Read codes included in the visual impairment category
2B69. O/E -R-eye counts fingers only
2B6A. O/E-R-eye perceives light only
2B6B. O/E - R-eye completely blind
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2B6C. O/E - R-eye sees hand movements
2B6P. O/E - pinhole R-eye sees hand movements
2B6Q. O/E - pinhole R-eye counts fingers only
2B6R. O/E - pinhole R-eye perceives light only
2B6S. O/E - pinhole R-eye completely blind
2B6T. O/E - R-eye visual acuity (corrected) 1/60
2B6V. O/E - R-eye visual acuity (corrected) 2/60
2B6W. O/E - R-eye visual acuity (corrected) 4/60
2B6X. O/E - R-eye visual acuity (corrected) 5/60
2B79. O/E -L-eye counts fingers only
2B7A. O/E-L-eye perceives light only
2B7B. O/E - L-eye completely blind
2B7C. O/E - L-eye sees hand movements
2B7P. O/E - pinhole L-eye sees hand movements
2B7Q. O/E - pinhole L-eye counts fingers only
2B7R. O/E - pinhole L-eye perceives light only
2B7S. O/E - pinhole L-eye completely blind
2B7T. O/E - L-eye visual acuity (corrected) 1/60
2B7V. O/E - L-eye visual acuity (corrected) 2/60
2B7W. O/E - L-eye visual acuity (corrected) 4/60
2B7X. O/E - L-eye visual acuity (corrected) 5/60
6688. Registered partially sighted
6689. Registered blind
668B. Poor visual acuity
668C. Certificate of vision impairment
F49. Blindness and low vision
F490. Blindness, both eyes
F4900 Unspecified blindness both eyes
F4901 Both eyes total visual impairment
F4902 Better eye: near total VI, Lesser eye: unspecified
F4903 Better eye: near total VI, Lesser eye: total VI
F4904 Better eye: near total VI, Lesser eye: near total VI
F4905 Better eye: profound VI, Lesser eye: unspecified
F4906 Better eye: profound VI, Lesser eye: total VI
F4907 Better eye: profound VI, Lesser eye: near total VI
F4908 Better eye: profound VI, Lesser eye: profound VI
F4909 Acquired blindness, both eyes
F490z Blindness both eyes NOS
F491. Better eye: low vision, Lesser eye: profound VI
F4910 One eye blind, one eye low vision
F4911 Better eye: severe VI, Lesser eye: blind, unspecified
F4912 Better eye: severe VI, Lesser eye: total VI
F4913 Better eye: severe VI, Lesser eye: near total VI
F4914 Better eye: severe VI, Lesser eye: profound VI
F4915 Better eye: moderate VI, Lesser eye: blind,
unspecified
F4916 Better eye: moderate VI, Lesser eye: total VI
F4917 Better eye: moderate VI, Lesser eye: near total VI
F4918 Better eye: moderate VI, Lesser eye: profound VI
F491z One eye blind, one eye low vision NOS
F492. Low vision, both eyes
F4920 Low vision, both eyes unspecified
F4921 Better eye: severe VI, Lesser eye: low vision
unspecified
F4922 Better eye: severe VI, Lesser eye: severe VI
F4923 Better eye: moderate VI, Lesser eye: low vision
unspecified
F4924 Better eye: moderate VI, Lesser eye: severe VI
F4925 Better eye: moderate VI, Lesser eye: moderate VI
F492z Low vision, both eyes NOS
F493. Visual loss, both eyes unqualified
F494. Legal blindness USA
F495. Profound impairment, one eye
F4950 Blindness, one eye, unspecified
F4951 Lesser eye: total visual impairment, Better eye:
unspecified
F4952 Lesser eye: total VI, Better eye: near normal vision
F4953 Lesser eye: total VI, Better eye: normal vision
F4954 Lesser eye: near total VI, Better eye: unspecified
F4955 Lesser eye: near total VI, Better eye: near nor-
mal vision
F4956 Lesser eye: near total VI, Better eye: normal vision
F4957 Lesser eye: profound VI, Better eye: unspecified
F4958 Lesser eye: profound VI, Better eye: near nor-
mal vision
F4959 Lesser eye: profound VI, Better eye: normal vision
F495A Acquired blindness, one eye
F495z Profound impairment one eye NOS
F496. Low vision, one eye
F4960 Low vision, one eye, unspecified
F4961 Lesser eye: severe VI, Better eye: unspecified
F4962 Lesser eye: severe VI, Better eye: near normal
vision
F4963 Lesser eye: severe VI, Better eye: normal vision
F4964 Lesser eye: moderate VI, Better eye: unspecified
F4965 Lesser eye: moderate VI, Better eye: near normal
vision
F4966 Lesser eye: moderate VI, Better eye: normal vision
F496z Low vision, one eye NOS
F49y. Visual loss, one eye, unqualified
F49z. Visual loss NOS
F49z0 Charles Bonnet syndrome
FyuL. [X]Visual disturbances and blindness
ZV410 [V]Problems with sight
Additional file
Additional file 1: Table S1. Definitions of 32 physical health
conditions assessed.
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